Live Breaking News & Updates on Uvenile ra

Stay informed with the latest breaking news from Uvenile ra on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Uvenile ra and stay connected to the pulse of your community

Two Biosimilars Approved in Europe for Autoimmune Disorders

The drugs are intended to treat several types of arthritis, psoriasis, COVID-19, and Crohn's disease.

Ukraine , China , Bulgaria , Poland , Georgia , United-states , European-union , Medicinal-products , Human-use , European-medicines-agency , Rheumatoid-arthritis-ra

Sub-Q Tocilizumab Gives Durable Long-Term Responses in JIA

Patients with juvenile idiopathic arthritis achieved long-term disease control with subcutaneous tocilizumab treatment, without any new safety concerns, in an LTE study of two trials.

Cincinnati , Ohio , United-states , Herminei-brunner , International-league , Cincinnati-children , Hospital-medical-center , Juvenile-rheumatoid-arthritis , Uvenile-ra , Uvenile-idiopathic-arthritis , Arthritis

Tocilizumab Withdrawal Post Remission in Still's Disease

Longer tocilizumab administration intervals and lower prednisolone doses seemed pivotal for successful tocilizumab withdrawal while maintaining remission in patients with AOSD.

Tokyo , Japan , Hiroya-tamai , Division-of-rheumatology , Department-of-internal-medicine , Keio-university-school-of-medicine , Internal-medicine , Keio-university-school , Biologic-therapy , Iologics , Remission , Juvenile-rheumatoid-arthritis

FDA OKs First Interchangeable Humira Biosimilar

It is the tenth adalimumab biosimilar approved by the regulatory agency.

United-states , Australia , Canada , Robert-wessman , European-union , Teva-pharmaceuticals , Pfizer , Boehringer-ingelheim , Drug-administration , Biologic-therapy , Iologics , Biosimilars

Diagnosing Infection in Tocilizumab Users: What's Helpful?

Area under the curve for routine biomarkers distinguished infected and noninfected adults with inflammatory diseases.

Reims , Champagne-ardenne , France , Audrey-glatre , University-hospital-centre-reims , Rheumatoid-arthritis-ra , Heumatoid-arthritis-ra- , Juvenile-rheumatoid-arthritis , Uvenile-ra , Uvenile-idiopathic-arthritis , Temporal-arteritis , Iant-cell-arteritis